ArticleInternational journal of MCH and AIDS2025
Improving HIV Prevention for Key Populations in Nigeria: Insights on Access, Barriers, Stigma, and Service Utilization.
Article in International journal of MCH and AIDS, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Barriers and Facilitators of Oral PrEP Uptake Against HIV Among Selected Priority Populations: A Global Perspective.Current HIV/AIDS reports · 2026Review
- A qualitative exploration of perceived risks, motivations, and risk management strategies among brothel-based female sex workers in Ibadan, Nigeria.BMC public health · 2025Article
- Package of interventions for harm reduction among women who inject drugs in Nigeria.Archives of public health = Archives belges de sante publique · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Objective: Human immunodeficiency virus and acquired immunodeficiency syndrome (HIV/AIDS) remains a significant public health challenge globally, with key populations (KPs) such as female sex workers (FSWs), men who have sex with men (MSM), and people who inject drugs (PWIDs) being disproportionately affected. Despite the availability of various HIV prevention services, including pre-exposure prophylaxis (PrEP) and community-based antiretroviral therapy (ART), the willingness of KPs to access these services remains a critical concern. This study aims to assess the prevalence of HIV and the willingness to access HIV preventive services among KPs in three selected local government areas (LGAs) in Nigeria. Methods: A cross-sectional study was conducted in 2023 across three LGAs, Gwale, Fagge, and Tarauni, in Kano State, Nigeria, using a snowball sampling technique. A total of 1,320 participants, recruited from brothels and nightclubs, were tested for HIV using self-test kits. Willingness to access HIV services was assessed using a structured questionnaire. Data were analyzed using descriptive statistics and binary logistic regression. Results: The overall HIV prevalence among KPs was 10.8%. MSM and PWIDs exhibited higher HIV prevalence rates compared to FSWs. Willingness to access HIV preventive services was recorded at 57.7%, with significant influences from geographical location and sexual practices. Participants from Tarauni were more willing to access services, and those engaging in vaginal sex were more likely to seek preventive services. HIV self-testing had a high uptake of 95.9%, while PrEP uptake was 68.0%. Major barriers included stigma, lack of comprehensive services, and limited knowledge of service providers. Conclusion and Global Health Implications: This study highlights the critical need for targeted interventions addressing the specific barriers faced by KPs in these regions. Enhancing service accessibility and addressing stigma is essential for reducing HIV transmission and achieving epidemic control in Nigeria by 2030.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.